CCS adapting to COVID-19 realities to support Canadians during and after the pandemic
Dr Nada Jabado
William E. Rawls Prize recipient in 2011
Dr Nada Jabado is an international leader in the field of pediatric brain cancers. As an oncologist and geneticist specializing in pediatric cancer, her research and clinical work has been dedicated to the understanding and treatment of brain cancers in children. Her recent research has opened a totally new genetic profiling approach in the predicted outcome and future management of these children.
Dr Jabado is a hematologist, oncologist and researcher at the McGill University Health Centre Montreal Children’s Hospital. She is also an associate professor, department of pediatrics and an associate member, department of medicine, division of experimental medicine at McGill University.
Since establishing her own laboratory in 2003, Dr Jabado has published more than 30 papers. In addition to her scientific successes, Dr Jabado is a caring physician and a remarkable clinician scientist dedicated to understanding one of the most dreadful pediatric cancers. Her work has accelerated potential treatments and new therapeutic regimes that promise to make a great difference in the lives of these children with cancer.
What’s the lifetime risk of getting cancer?
The latest Canadian Cancer Statistics report shows about half of Canadians are expected to be diagnosed with cancer in their lifetime.